Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst. 2005 Apr 06; 97(7):489-98.